Price control, ad-hoc regulatory changes may hamper pharma sector growth: Pfizer
Mumbai, Sep 2: Pharma major Pfizer fears that the pharma industry is expected to face challenges from price controls, ad-hoc regulatory changes and new policies that may impact sustainable growth....
Read moreDetails









